As of --
|-- -- / --|
The 1 analysts offering 12-month price forecasts for Madrigal Pharmaceuticals Inc have a median target of 0.65, with a high estimate of 0.65 and a low estimate of 0.65. The median estimate represents a -- increase from the last price of --.
The current consensus among 1 polled investment analysts is to Hold stock in Madrigal Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.